Matthias Friebe Selected Research

Matthias Friebe Research Topics

Disease

12	Neoplasms (Cancer) 01/2016 - 01/2004
3	Melanoma (Melanoma, Malignant) 01/2014 - 12/2002
2	Prostatic Neoplasms (Prostate Cancer) 03/2015 - 11/2013
2	Alzheimer Disease (Alzheimer's Disease) 11/2012 - 02/2008
1	Thrombosis (Thrombus) 01/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2016
1	Brain Neoplasms (Brain Tumor) 01/2016
1	Inflammation (Inflammations) 09/2011
1	Breast Neoplasms (Breast Cancer) 07/2008
1	Dementia (Dementias) 02/2008
1	Teratocarcinoma 10/2005

Drug/Important Bio-Agent (IBA)

3	Glutamic Acid (Glutamate)FDA Link 01/2016 - 01/2011
3	Bombesin Receptors (Bombesin Receptor)IBA 03/2015 - 09/2008
3	BombesinIBA 03/2015 - 09/2008
3	BenzamidesIBA 01/2014 - 12/2002
3	benzamideIBA 01/2014 - 12/2002
3	Fibronectins (Fibronectin)IBA 07/2007 - 10/2005
2	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 01/2011
2	Amino Acids FDA Link 01/2016 - 01/2011
2	RadiopharmaceuticalsIBA 01/2016 - 01/2014
2	Melanins (Melanin)IBA 01/2014 - 05/2010
2	Radioisotopes (Radionuclides)IBA 01/2014 - 01/2004
2	Pharmaceutical PreparationsIBA 11/2012 - 05/2010
2	AcidsIBA 01/2011 - 05/2010
2	Immunoglobulin FragmentsIBA 07/2007 - 10/2006
1	Platelet Glycoprotein GPIIb-IIIa ComplexIBA 01/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2016
1	benzo(1,3)dioxolo-5-carboxylic acid (4- (2- diethylaminoethylcarbamoyl)- 2- iodo- 5- methoxyphenyl)amideIBA 01/2014
1	CalciumIBA 11/2013
1	Amyloid (Amyloid Fibrils)IBA 11/2012
1	TurpentineIBA 09/2011
1	(4S)-4-(3-(18F)fluoropropyl)-L-glutamateIBA 09/2011
1	Glutamine (L-Glutamine)FDA Link 01/2011
1	N- (2- diethylaminoethyl)- 4- (4- fluorobenzamido)- 5- iodo- 2- methoxybenzamideIBA 05/2010
1	SiliconIBA 09/2008
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 07/2008
1	Neuropeptide YIBA 07/2008
1	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 02/2008
1	Amyloid beta-PeptidesIBA 02/2008
1	Extracellular Matrix ProteinsIBA 10/2006
1	Immunoconjugates (Immunoconjugate)IBA 10/2005
1	TenascinIBA 01/2004
1	ElementsIBA 12/2002
1	4- (S- benzoyl- 2- thioacetyl- glycyl- glycylamido)- N- (2- diethylaminoethyl)benzamideIBA 12/2002
1	N-(2-diethylaminoethyl)benzamideIBA 12/2002
1	LigandsIBA 12/2002

Therapy/Procedure

3	Therapeutics 01/2014 - 10/2005
1	Catheters 01/2017
1	Radiotherapy 05/2010
1	Radioimmunotherapy 10/2005